Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay
Craig W. Freyer(Hospital of the University of Pennsylvania), David Porter(University of Pennsylvania), Daria V. Babushok(Hospital of the University of Pennsylvania), Selina M. Luger(University of Pennsylvania), Shannon Gier(University of Pennsylvania), James K. Mangan(UC San Diego Health System), Natasha Berryman(Hospital of the University of Pennsylvania), Edward A. Stadtmauer(University of Pennsylvania), Mary E. Moyer(Hospital of the University of Pennsylvania), Alexander E. Perl(University of Pennsylvania), Alex Ganetsky(Hospital of the University of Pennsylvania), Jacqueline Smith(Roslin Institute), Alison W. Loren(University of Pennsylvania), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Colleen Timlin(Hospital of the University of Pennsylvania), Alison Carulli(Hospital of the University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Mary Ellen Martin(University of Pennsylvania)
Cited by 3
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k